In patients with the TNBC IM, the adaptive immune response and interferon-gamma signaling gene expression are prominent [114]; these activated pathways coincide with the pathways that were most activated by GSEA analysis for CCCR5+ vs. CCR5− breast tumors [11]. Here, CCR5 is linked to breast neoplasm.